06118.HK
Austar Lifesciences Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 0.70
+0.00%Year over year
Reported trailing growth
- Revenue
- -14.6%
- EBITDA
- +33.0%
- EBIT
- +216.5%
- EPS
- +391.2%
- Free cash flow
- +280.3%
- Operating cash flow
- +890.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -10.8%
- EBITDA
- -23.0%
- EBIT
- -22.5%
- Net income
- -27.2%
- EPS
- -27.0%
- Free cash flow
- +27.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026